Antihypertensive prescriptions over a 10-year period in a large Chinese population

American Journal of Hypertension

Volumn 26, Issue 7, 2013, Pages 931-938

  Wong, Martin C S ^a   Tam, Wilson W S ^a   Cheung, Clement S K ^b   Tong, Ellen L H ^b   Sek, Antonio C H ^b   Cheung, N T ^b   Yan, Bryan P Y ^a   Yu, Cheuk Man ^a   Griffiths, Sian M ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b HOSPITAL AUTHORITY   (Hong Kong)

Author keywords

antihypertensive agents; blood pressure; drug class; evidence based practice; hypertension; prescriptions trends

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; HEALTH CARE SYSTEM; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DRUG CLASS; EVIDENCE-BASED PRACTICE; HYPERTENSION; PRESCRIPTIONS TRENDS.;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; DRUG PRESCRIPTIONS; FEMALE; HONG KONG; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MORBIDITY; REGISTRIES; RETROSPECTIVE STUDIES;

EID: 84878874959     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpt049     Document Type: Article

References (32)

1. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease: part I-prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774.
2. Gueyffier F, Boutitie F, Boissel JP, Pocock S, Coope J, Cutler J, Ekbom T, Fagard R, Friedman L, Perry M, Prineas R, Schron E. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men: a meta-analysis of individual patient data from randomized, controlled trials-INDANA Investigators. Ann Intern Med 1997; 126:761-767.
3. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease: part 2-short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990; 335:827-838.
4. Gu Q, Paulose-Ram R, Dillon C, Burt V. Antihypertensive medication use among US adults with hypertension. Circulation 2006; 113:213-221.
5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252.
6. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288:2981-2997.
7. Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, Weiss NS. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003; 289:2534-2544.
8. 2003 European Society of Hypertension. European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
9. The Hong Kong Government. Hong Kong Reference Framework for Hypertension Care for Adults in Primary Care Settings. 2010. http://www.fhb.gov.hk/download/ press-and-publications/otherinfo/101231-primary-care/e-hypertension-care.pdf. Accessed 3 May 2012.
10. Williams B. Beta-blockers and the treatment of hypertension. J Hypertens 2007; 25:1351-1353.
11. Williams B. The obese hypertensive: the weight of evidence against beta-blockers. Circulation 2007; 115:1973-1974.
12. Xie F, Petitti DB, Chen W. Prescribing patterns of antihypertensive drugs after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: report of experience in a health maintenance organization. Am J Hypertens 2005; 18:464-469.
13. Austin PC, Mamdani MM, Tu K, Zwarenstein M. Changes in prescribing patterns following publication of the ALLHAT trial. JAMA 2004; 291:44-45.
14. Ma J, Lee K-.V, Stafford RS. Changes in antihypertensive prescribing during US outpatient visits for uncomplicated hypertension between 1993 and 2004. Hypertension 2006; 48:846-852.
15. Wong MC, Jiang JY, Lam AT, Fung H, Griffiths S, Mercer SW. Patterns of antihypertensive prescribing, discontinuation and switching among a Hong Kong Chinese population from over one million prescriptions. J Hum Hypertens 2008; 22:714-716.
16. Cheung NT, Health Informatics, Hospital Authority, Hong Kong. Realizing the Benefits of eHealth in Hong Kong. http://www.ehealth. org.hk/Speaker/ Dr%20Ngai%20Tseung%20CHEUNG.pdf . Accessed 20 June 2011
17. Wong MCS, Jiang JY, Tang JL, Lam A, Fung H, Mercer SW. Health services research in the public healthcare system in Hong Kong: an analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data. BMC Health Services Res 2008; 8:138
18. Population by Census, 2006, Hong Kong Special Administrative Region, China. http://www.bycensus2006.gov.hk/data/data2/index. htm . Accessed 3 May 2012
19. Census and Statistics Department. The Government of the Hong Kong Administrative Region. http://www.censtatd.gov.hk/hong-kong-statistics/ statistics-by-subject/index.jspsubjectID=1&charsetID=1&disp layMode=T. Accessed 3 May 2012
20. Cox DR, Stuart A. Some quick tests for trend and dispersion. Biometrika 1955; 42:80-95.
21. Wong MC, Tam WW, Cheung CS, Tong EL, Sek AC, John G, Cheung NT, Yan BP, Yu CM, Leeder S, Griffiths S. Initial antihypertensive prescription and switching: a 5 year cohort study from 250,851 patients. PLoS One 2013; 8:e53625.
22. Anonymous. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413-2446.
23. Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension A meta-analysis. Lancet 2005; 366:1545-1553
24. Messerli FH, Grossman E. Therapeutic controversies in hypertension. Semin Nephrol 2005; 366:1545-1553.
25. Stafford RS, Monti V, Furberg CD, Ma J. Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States. Hypertension 2006; 48:213-218.
26. Campbell NRC, Tu K, Brant R, Duong-Hua M, McAlister FA. The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends. Hypertension 2006; 47:22-28.
27. Player MS, Gill JM, Fagan HB, Mainous AG III. Antihypertensive prescribing practices: impact of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attach Trial. J Clin Hypertens 2006; 12:860-864.
28. Maio V, Gagne JJ. Impact of ALLHAT publication on antihypertensive prescribing patterns in Regione Emilia-Romagna, Italy. J Clin Pharm Ther 2010; 35:55-61.
29. Kretzer K, Juarez DT, Davis J. Initial antihypertensive prescriptions, switching patterns and adherence among insured patients in Hawai'i. Hawaii Med J 2008; 67:96-111.
30. Liu PH, Wang JD. Antihyertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan. BMC Health Services Res 2008; 8:133
31. Wang TJ, Ausiello JC, Stafford RS. Trends in antihypertensive drug advertising, 1985-1996. Circulation 1999; 99:2055-2057.
32. Stafford RS, Furberg CD, Finkelstein SN, Cockburn IM, Alehegn T, Ma J. Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002. JAMA 2004; 291:54-62.